Biogen Derivative Liability, Current decreased by 32.6% to $38.20M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates that hedging positions are currently out-of-the-money, potentially requiring cash settlement in the near term.
The fair value of derivative contracts that are in a liability position and are expected to be settled within one year....
Common in commodity-heavy businesses; reflects the impact of market volatility on hedging portfolios.
current_liabilities_derivative_liabilities_current| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $56.70M | $38.20M |
| QoQ Change | — | -32.6% |